HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?

AuthorsL Orlando, M Colleoni, F Nolè, R Biffi, A Rocca, G Curigliano, G Ferretti, G Peruzzotti, F de Braud, G Masci, A Goldhirsch
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 11 Issue 1 Pg. 117-8 (Jan 2000) ISSN: 0923-7534 [Print] England
PMID10690401 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Vinblastine
  • Cisplatin
  • Vinorelbine
  • Fluorouracil
Topics
  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects)
  • Breast Neoplasms (drug therapy)
  • Cisplatin (administration & dosage)
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Incidence
  • Infusions, Intravenous
  • Middle Aged
  • Retrospective Studies
  • Thromboembolism (chemically induced, prevention & control)
  • Venous Thrombosis (chemically induced, prevention & control)
  • Vinblastine (administration & dosage, analogs & derivatives)
  • Vinorelbine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: